SKI Market

A+| A| A-|

Indian Indices

Sensex

77,664.00 -852.49
( -1.09%)

Global Indices

Nasdaq

49,509.71 339.32
(0.69%)

Dow Jones

7,158.76 73.75
(1.04%)

Hang Seng

59,249.10 -336.76
(-0.57%)

Nikkei 225

10,468.22 -8.24
(-0.08%)

Forex

USD-INR

93.44 0.45
(0.48%)

EUR-INR

109.88 0.43
(0.39%)

GBP-INR

126.24 0.55
(0.44%)

JPY-INR

0.59 0.00
(0.27%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

36.79

34689.63

EPS(TTM)

Face Value()

Div & Yield %

75.48

1.01

Back

Manipal Finance Corporation standalone net profit declines 95.91% in the December 2025 quarter

Feb 13,2026

Net profit of Manipal Finance Corporation declined 95.91% to Rs 0.30 crore in the quarter ended December 2025 as against Rs 7.33 crore during the previous quarter ended December 2024. Sales remain constant at Rs 0.05 crore in the quarter ended December 2025 and also during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0.05	0.05	0
OPM %	-80.00	-160.00	-
PBDT	-0.05	-0.14	64
PBT	-0.05	-0.14	64
NP	0.30	7.33	-96

77,664.00 -852.49 ( -1.09%)

49,509.71 339.32 (0.69%)

7,158.76 73.75 (1.04%)

59,249.10 -336.76 (-0.57%)

10,468.22 -8.24 (-0.08%)

93.44 0.45 (0.48%)

109.88 0.43 (0.39%)

126.24 0.55 (0.44%)

0.59 0.00 (0.27%)